Federal Register / Vol. 82, No. 188 / Friday, September 29, 2017 / Notices 45589 

www.regulations.gov, including any 

personal or proprietary information 

provided. To download an electronic 

version of the Guideline and 

appendices, go to http://

www.regulations.gov. 

FOR FURTHER INFORMATION CONTACT: 

Arlene Greenspan, National Center for 

Injury Prevention and Control, Centers 

for Disease Control and Prevention, 

4770 Buford Highway NE., Mailstop F– 

63, Atlanta, Georgia 30341; Telephone: 

(770) 488–4696. 

SUPPLEMENTARY INFORMATION: The 

Pediatric Mild Traumatic Brain Injury 

Workgroup, a workgroup of the National 

Center for Injury Prevention and Control 

(NCIPC) Board of Scientific Counselors 

(BSC), conducted a systematic review of 

the evidence and drafted the clinical 

recommendations. The NCIPC/BSC is a 

federal advisory committee comprised 

of leading experts in the field of injury 

and violence prevention that makes 

recommendations to the HHS Secretary, 

the CDC Director, and the NCIPC 

Director. The workgroup consists of 

subject matter experts in neurosurgery, 

pediatrics, emergency medicine, 

nursing, neurology, rehabilitation, 

neuroimaging, internal and family 

medicine, sports medicine, and school 

health. The systematic review and 

clinical recommendations drafted by the 

Pediatric Mild Traumatic Brain Injury 

Workgroup served as the primary 

foundation for the CDC Systematic 

Review and CDC Guideline. 

Supporting and Related Material in the 

Docket 

The docket contains the following 

supporting and related materials to help 

inform public comment: the Systematic 

Review including data tables, and the 

Guideline including the key 

recommendations. The document, 

Diagnosis and Management of Mild 

Traumatic Brain Injury Among 

Children: A Systematic Review, 

summarizes findings from 25 years of 

research on the diagnosis, prognosis, 

and management of pediatric mild TBI. 

In this review, evidence is summarized 

for six clinical questions using a 

rigorous evidence rating methodology. 

The draft CDC Guideline on the 

Diagnosis and Management of Mild 

Traumatic Brain Injury Among Children 

focuses on diagnosis and management 

of acute mild traumatic brain injury 

(TBI) among children and adolescents 

(age 18 and under). The Guideline is 

designed for use by acute care and 

primary care providers who diagnose 

and manage patients with mild TBI 

resulting from both unintentional and 

intentional injuries. The 

recommendations contained in the 

Guideline were developed based on 

findings from the Systematic Review. 

This Guideline is not a federal rule or 

regulation; adherence to the Guideline 

will be voluntary. 

Dated: September 26, 2017. 

Sandra Cashman, 

Executive Secretary, Centers for Disease 

Control and Prevention. 

[FR Doc. 2017–20903 Filed 9–28–17; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers CMS–10224, CMS– 

222–17, CMS–216–94, and CMS–265–11] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including the necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions, the accuracy of 

the estimated burden, ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and the use 

of automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by October 30, 2017. 

ADDRESSES: When commenting on the 

proposed information collections, 

please reference the document identifier 

or OMB control number. To be assured 

consideration, comments and 

recommendations must be received by 

the OMB desk officer via one of the 

following transmissions: OMB, Office of 

Information and Regulatory Affairs, 

Attention: CMS Desk Officer, Fax 

Number: (202) 395–5806 Or, Email: 

OIRA_submission@omb.eop.gov. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ Web site address at 

https://www.cms.gov/Regulations-andGuidance/Legislation/ 

PaperworkReductionActof1995/PRAListing.html. 

2. Email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov. 

3. Call the Reports Clearance Office at 

(410) 786–1326. 

FOR FURTHER INFORMATION CONTACT: 

William Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. The term ‘‘collection of 

information’’ is defined in 44 U.S.C. 

3502(3) and 5 CFR 1320.3(c) and 

includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires federal agencies 

to publish a 30-day notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension or 

reinstatement of an existing collection 

of information, before submitting the 

collection to OMB for approval. To 

comply with this requirement, CMS is 

publishing this notice that summarizes 

the following proposed collection(s) of 

information for public comment: 

1. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Healthcare 

Common Procedure Coding System 

(HCPCS)—Level II Code Modification 

Request Process; Use: In October 2003, 

the Secretary of Health and Human 

Services (HHS) delegated authority 

under the Health Insurance Portability 

and Accountability Act (HIPAA) 

legislation to Centers for Medicare and 

Medicaid Services (CMS) to maintain 

and distribute HCPCS Level II Codes. As 

stated in 42 CFR Sec. 414.40(a) CMS 

establishes uniform national definitions 

of services, codes to represent services, 

and payment modifiers to the codes. 

The HCPCS codeset has been 


asabaliauskas on DSKBBXCHB2PROD with NOTICES
45590 Federal Register / Vol. 82, No. 188 / Friday, September 29, 2017 / Notices 

maintained and distributed via 

modifications of codes, modifiers and 

descriptions, as a direct result of data 

received from applicants. Thus, 

information collected in the application 

is significant to codeset maintenance. 

The HCPCS codeset maintenance is 

an ongoing process, as changes are 

implemented and updated annually; 

therefore, the process requires continual 

collection of information from 

applicants on an annual basis. As new 

technology evolves and new devices, 

drugs and supplies are introduced to the 

market, applicants submit applications 

to CMS requesting modifications to the 

HCPCS Level II codeset. Applications 

have been received prior to HIPAA 

implementation and must continue to 

be collected to ensure quality decisionmaking. The HIPAA of 1996 required 

CMS to adopt standards for coding 

systems that are used for reporting 

health care transactions. The regulation 

that CMS published on August 17, 2000 

(45 CFR 162.10002) to implement the 

HIPAA requirement for standardized 

coding systems established the HCPCS 

Level II codes as the standardized 

coding system for describing and 

identifying health care equipment and 

supplies in health care transactions. 

HCPCS Level II was selected as the 

standardized coding system because of 

its wide acceptance among both public 

and private insurers. Public and private 

insurers were required to be in 

compliance with the August 2000 

regulation by October 1, 2002. Form 

Number: CMS–10224 (OMB control 

number: 0938–1042); Frequency: 

Annually; Affected Public: Private 

Sector: Business or other for-profit, Notfor-profit institutions; Number of 

Respondents: 100; Total Annual 

Responses: 100; Total Annual Hours: 

1100. (For policy questions regarding 

this collection contact Kimberley 

Combs-Miller at 410–786–6707). 

2. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Independent 

Rural Health Clinics/Freestanding 

Federally Qualified Health Clinics Cost 

Report; Use: Providers of services 

participating in the Medicare program 

are required under sections 1815(a), 

1833(e) and 1861(v)(1)(A) of the Social 

Security Act (42 U.S.C. 1395g) to submit 

annual information to achieve 

settlement of costs for health care 

services rendered to Medicare 

beneficiaries. In addition, regulations at 

42 CFR 413.20 and 413.24 require 

adequate cost data and cost reports from 

providers on an annual basis. The Form 

CMS–222–17 cost report is needed to 

determine a provider’s reasonable costs 

incurred in furnishing medical services 

to Medicare beneficiaries and 

reimbursement due to or from a 

provider. Form Number: CMS–222–17 

(OMB control number: 0938–0107); 

Frequency: Annually; Affected Public: 

Private Sector: Business or other forprofit, Not-for-profit institutions; 

Number of Respondents: 1,744; Total 

Annual Responses: 1,744; Total Annual 

Hours: 95,920. (For policy questions 

regarding this collection contact Yaakov 

Feinstein at 410–786–3137). 

3. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Organ 

Procurement Organization/ 

Histocompatibility Laboratory Cost 

Report; Use: Providers of services 

participating in the Medicare program 

are required under sections 1815(a) and 

1861(v)(1)(A) of the Social Security Act 

(42 U.S.C. 1395g) to submit annual 

information to achieve settlement of 

costs for health care services rendered to 

Medicare beneficiaries. In addition, 

regulations at 42 CFR 413.20 and 413.24 

require adequate cost data and cost 

reports from providers on an annual 

basis. The Form CMS–216–94 cost 

report is needed to determine a 

provider’s reasonable costs incurred in 

furnishing medical services to Medicare 

beneficiaries and reimbursement due to 

or due from a provider. Form Number: 

CMS–216–94 (OMB control number: 

0938–0102); Frequency: Annually; 

Affected Public: Private Sector: Business 

or other for-profit, Not-for-profit 

institutions; Number of Respondents: 

102; Total Annual Responses: 102; Total 

Annual Hours: 4590. (For policy 

questions regarding this collection 

contact Amelia Citerone at 410–786– 

3901). 

4. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Providers of 

services participating in the Medicare 

program are required under sections 

1815(a) and 1861(v)(1)(A) of the Social 

Security Act (42 U.S.C. 1395g) to submit 

annual information to achieve 

settlement of costs for health care 

services rendered to Medicare 

beneficiaries. In addition, regulations at 

42 CFR 413.20 and 413.24 require 

adequate cost data and cost reports from 

providers on an annual basis. The Form 

CMS–265–11 cost report is needed to 

determine a provider’s reasonable costs 

incurred in furnishing medical services 

to Medicare beneficiaries. Form 

Number: CMS–265–11 (OMB control 

number: 0938–0236); Frequency: 

Annually; Affected Public: Private 

Sector: Business or other for-profit, Notfor-profit institutions; Number of 

Respondents: 6,821; Total Annual 

Responses: 6,821; Total Annual Hours: 

443,365. (For policy questions regarding 

this collection contact Gail Duncan at 

410–786–7278). 

Dated: September 26, 2017. 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2017–20921 Filed 9–28–17; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–1698–N] 

Medicare Program; Request for 

Nominations to the Medicare Advisory 

Panel on Clinical Diagnostic 

Laboratory Tests 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice. 

SUMMARY: This notice requests 

nominations to fill vacancies on the 

Medicare Advisory Panel on Clinical 

Diagnostic Laboratory Tests (the Panel). 

The purpose of the Panel is to advise the 

Secretary of the Department of Health 

and Human Services (DHHS) and the 

Administrator of the Centers for 

Medicare & Medicaid Services (CMS) on 

issues related to clinical diagnostic 

laboratory tests (CDLTs). As announced 

in the notice published in the Federal 

Register on June 16, 2017, entitled 

‘‘Medicare Program; Rechartering, 

Membership, and Announcement of the 

Advisory Panel on Clinical Diagnostic 

Laboratory Tests Meeting on August 1, 

2017’’ (82 FR 27705), the Secretary 

approved the rechartering of the Panel 

on April 25, 2017 for a 2-year period 

effective through April 25, 2019. 

DATES: The agency will receive 

nominations on a continuous basis. 

ADDRESSES: All nominations should be 

sent electronically to the following 

email address: CDLTPanel@

cms.hhs.gov. 

Web site: For additional information 

on the Panel and updates to the Panel’s 

activities, we refer readers to our Web 

site at http://cms.gov/Regulations-andGuidance/Guidance/FACA/ 

AdvisoryPanelonClinicalDiagnostic

LaboratoryTests.html. 

FOR FURTHER INFORMATION CONTACT: 

Persons wishing to nominate 

individuals to serve on the Panel or to 


asabaliauskas on DSKBBXCHB2PROD with NOTICES